Pretzel Therapeutics
PrivateLast Round
VC Round
Jul 11, 2025
Total Funding Raised
$72.5M
Company Overview
Pretzel Therapeutics is a biotechnology company developing first-in-class therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pretzel Therapeutics Comparables
Compare Pretzel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 85% | |
| Vincerx Pharma | 78% | |
| Pharming Group N.V. | 78% |
Pretzel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 11, 2025 | ||||
| Series A | Sep 12, 2022 |
Pretzel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vasa Angels I | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| United Mitochondrial Disease Foundation | VC Round |
| HealthCap | Series A |
| Eir Ventures | Series A |
| Invus Opportunities | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2026
PX578 data presented at the 2026 MDA Clinical & Scientific Conference.
- Mar 11, 2026
Presented data at the 2026 MDA Clinical & Scientific Conference.
Pretzel Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pretzel Therapeutics's valuation, stock price, and market status.
Is Pretzel Therapeutics a public or private company?
Pretzel Therapeutics is a private company.
What is the current stock price of Pretzel Therapeutics?
Pretzel Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pretzel Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pretzel Therapeutics worth (valuation)?
Valuation information for Pretzel Therapeutics is not publicly available.
Can I buy Pretzel Therapeutics stock?
Pretzel Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pretzel Therapeutics's last funding round?
Pretzel Therapeutics's most recent funding round was VC Round on July 11, 2025.
Who are the main investors in Pretzel Therapeutics?
Key investors in Pretzel Therapeutics include ARCH Venture Partners, United Mitochondrial Disease Foundation, ARCH Venture Partners, Mubadala Capital.
Will Pretzel Therapeutics IPO soon?
No public IPO plans have been announced for Pretzel Therapeutics.
How can I track Pretzel Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pretzel Therapeutics's shares on secondary markets.